Korean name: HK 나토배양물. This page reports what South Korea's
Ministry of Food and Drug Safety has approved for this ingredient.
MFDS recognition no.
2009-50
Approval route
Notified (고시형) — listed in MFDS public standards
Daily intake (as approved)
133.0–133.0 mg
Approval holder
(주)HK바이오텍
Approved functional claim (Korean original)
The text below is the approved wording as published by MFDS. It is reproduced without
modification. Any translation is provided for comprehension only and carries no regulatory
standing.
혈액의 흐름을 방해할 수 있는 혈소판응집을 억제하여, 혈액흐름을 원활히 하는데 도움을 줄 수 있음(기타 II)
Precautions (Korean original)
1) 알레르기 체질이신 분은 원재료를 확인하신 후 섭취하십시오.
2) 임산부와 수유기 여성은 섭취를 피하는 것이 좋습니다.
3) 과다 섭취시 혈액응고가 저해되어 출혈 위험이 증가될 수 있습니다.
4) 항혈전 관련 약품(항응고제, 항혈소판제제)을 섭취하는 사람은 의사와 상담 후 섭취하여야 합니다.
5) 수술 전과 후에는 섭취를 피해야 합니다.
What this means for sourcing
An ingredient approved in Korea is not automatically permitted elsewhere. Importers should
verify status with their own authority. Conversely, Korean approval demonstrates that a dossier
on safety and function was reviewed under a national regulatory system, which many buyers treat
as a meaningful signal.
Regulatory approvals described on this page were issued by the Ministry of Food and Drug Safety (MFDS) of the Republic of Korea and are valid in South Korea only. They are not health claims in your jurisdiction and have not been evaluated by the FDA, EFSA, or any other authority. This page reports regulatory facts; it does not recommend or endorse any product.